“Nationally nearly half of all Medicare Advantage enrollees are now eligible for prior authorization and reimbursement for ReWalk 7,” said Mark Grant, CEO of Lifeward. “This prior authorization ...

ReWalk Robotics Ltd. (Nasdaq: RWLK), the leading global exoskeleton manufacturer, unveiled today the latest edition of its Personal powered exoskeleton system—the ReWalk Personal 6.0—marking the ...

2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons. Final rule expedites access for Medicare beneficiaries to exoskeleton technology that enables individuals ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, July 05, 2023 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or “the Company”), a leading provider of innovative technologies that ...

Lifeward Ltd. LFWD recently announced that it has received CE mark approval for the ReWalk 7 Personal Exoskeleton. Following this approval, the seventh generation of the ReWalk is now cleared for ...

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its ...

Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd ...

Lifeward had a second executive join its C-suite transition in two months as the Marlborough-based medical device has selected its new CFO. Lifeward mobility products will be available in six new ...

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S., accounting for 47% of all Medicare Advantage enrollees This latest ...

Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk ...